David A. Siegel Liva Nova PLC Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Liva Nova PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 115,245 shares of LIVN stock, worth $6.32 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
115,245
Previous 106,445
8.27%
Holding current value
$6.32 Million
Previous $5.51 Million
17.05%
% of portfolio
0.02%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding LIVN
# of Institutions
252Shares Held
56.2MCall Options Held
367KPut Options Held
597K-
Black Rock Inc. New York, NY7.35MShares$403 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.94MShares$325 Million0.25% of portfolio
-
Barrow Hanley Mewhinney & Strauss LLC Dallas, TX2.36MShares$129 Million0.47% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.28MShares$125 Million0.06% of portfolio
-
State Street Corp Boston, MA2MShares$110 Million0.01% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.94B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...